Drug Profile
Q5-drug conjugate - Alteogen
Alternative Names: ALT Q5Latest Information Update: 28 Jun 2023
Price :
$50
*
At a glance
- Originator Alteogen
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 28 Jun 2023 No recent reports of development identified for preclinical development in Ovarian-cancer in South Korea (Parenteral)
- 27 May 2019 Preclinical trials in Ovarian cancer in South Korea (Parenteral) (Alteogen pipeline, May 2019)
- 28 Apr 2017 Early research in Ovarian cancer in South Korea (Parenteral)